Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Johnson and Johnson
Deloitte
Boehringer Ingelheim
Citi
US Department of Justice
Cantor Fitzgerald
Teva

Generated: April 20, 2018

DrugPatentWatch Database Preview

ATORVASTATIN CALCIUM Drug Profile

« Back to Dashboard

When do Atorvastatin Calcium patents expire, and when can generic versions of Atorvastatin Calcium launch?

Atorvastatin Calcium is a drug marketed by Accord Hlthcare, Apotex Inc, Dr Reddys Labs Ltd, Invagen Pharms, Kremers Urban Pharms, Mylan Pharms Inc, Sandoz Inc, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms, and Teva Pharms Usa. and is included in twelve NDAs.

The generic ingredient in ATORVASTATIN CALCIUM is atorvastatin calcium. There are sixty-one drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the atorvastatin calcium profile page.
Drug patent expirations by year for ATORVASTATIN CALCIUM
Pharmacology for ATORVASTATIN CALCIUM
Medical Subject Heading (MeSH) Categories for ATORVASTATIN CALCIUM
Synonyms for ATORVASTATIN CALCIUM
(|AR,|AR)-2-(4-Fluorophenyl)-|A,|A-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt
(C33H34FN2O5)2.Ca
(R,R)-2-(4-Fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt
[R-(R*, R*)]-2-(4-fluorophenyl)-(beta), (delta)-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, calcium salt (2:1) trihydrate
[R-(R*, R*)]-2-(4-fluorophenyl)-beta-, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid,calcium salt (2:1) trihydrate
1108202-55-6
110862-48-1 (Parent)
134523-03-8
1370463-14-1
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-,-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (R,R)-
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, calcium salt (2:1), (R-(R*,R*))-
1H-Pyrrole-1-heptanoic acid, beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, calcium salt (2:1), (R-(R*,R*))-
2C33H34FN2O5.Ca
334757-04-9
4CA-0208
AC1L1TZQ
ACT03226
AK106989
AKOS015896435
AM90286
AN-6412
AOB6343
AT-3134
Atorvastan
Atorvastatin calcium [USAN:USP]
Atorvastatin calcium [USAN]
Atorvastatin calcium anhydorous
Atorvastatin calcium anhydrous
Atorvastatin calcium salt
Atorvastatin Hemicalcium
Atorvastatin hemicalcium salt
BB_SC-4721
BC634906
BDBM50442868
C0GEJ5QCSO
CA0146
calcium (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate
calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
calcium (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate
Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2)
calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate)
calcium bis{(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate}
calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
CAS-134523-03-8
CHEBI:50686
CHEMBL393220
CI 981
CI-981
D00887
DRG-0321
DSSTox_CID_24303
DSSTox_GSID_44303
DSSTox_RID_80143
DTXSID6044303
FQCKMBLVYCEXJB-MNSAWQCASA-L
FT-0081085
GS-3563
HE307391
I06-1867
J-006551
KB-270796
Kolevas
KS-00000IS3
Lipibec
Lipitor
LS-136974
MFCD00899261
MolPort-003-986-383
NCGC00159458-03
NCGC00159458-05
NCGC00255845-01
PD 134298-38A
Prevencor
Ranbaxy's Storvas
Rotacor
SC-76963
SCHEMBL3832
Sortis
Storvas
SYN3020
Tahor
TL8000809
Torvast
Tox21_111685
Tox21_111685_1
Tox21_302373
UNII-C0GEJ5QCSO
VA10343
YM 548
YM-548

US Patents and Regulatory Information for ATORVASTATIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 205300-001 Mar 27, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sciegen Pharms Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 205519-004 May 19, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 077575-004 May 29, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 076477-001 Nov 30, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
McKinsey
Citi
Merck
AstraZeneca
Daiichi Sankyo
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.